2024-517756-35-00招募中1 期
A study to learn about the study medicine called PF-08046032 in people with advanced cancers.
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 发起方
- Pfizer Inc.
- 入组人数
- 33
- 试验地点
- 3
研究概览
简要总结
暂无简介。
入排标准
- 年龄范围
- 18 years 至 65+ years（18-64 Years, 65+ Years）
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
研究者
Clinical Medical Lead
Scientific
Pfizer Inc.
研究点 (3)
Loading locations...
相似试验
招募中
不适用
A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe AsthmaAsthmajRCT2031250163Pfizer Japan Inc.252
招募中
不适用
A Study to Learn About the Study Medicine Called PF-07868489 in People With Pulmonary Arterial HypertensionPulmonary Arterial HypertensionjRCT2051240229Pfizer Japan Inc.90
进行中（未招募）
不适用
A Study to Learn About the Study Medicine Called PF-07220060 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of TreatmentjRCT2051230196Pfizer Japan Inc.510
招募中
不适用
A Study to Learn About the Study Medicine Called PF-07321332 (Nirmatrelvir)/Ritonavir in Patients Under 18 Years of Age With COVID-19 That Are Not Hospitalized But Are at Risk for Severe Disease (EPIC-Peds)jRCT2031250096Pfizer Japan Inc.160
尚未招募
不适用
A Study to Learn About the Study Medicine Called PF-07328948 in Adults With Heart Failure (BRANCH-HF) (BRANCH-HF)jRCT2031250168Pfizer Japan Inc.620